Related Experiment Video
Updated: Oct 29, 2025
Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis
Anthony K Akobeng1,2, Ciaran Grafton-Clarke3, Ibtihal Abdelgadir2,4
1Division of Gastroenterology, Hepatology, and Nutrition, Sidra Medicine, Doha, Qatar.
Insights
Approximately 23% of children with COVID-19 experience gastrointestinal symptoms like diarrhea and vomiting. Awareness of these gastrointestinal manifestations is crucial for pediatric care.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Public Health
Background:
- The novel coronavirus (COVID-19) pandemic has impacted global health, with varying clinical presentations across age groups.
- Gastrointestinal (GI) manifestations in children with COVID-19 require further elucidation to guide clinical management.
Conclusions:
- A significant proportion, nearly a quarter, of children with COVID-19 exhibit gastrointestinal symptoms.
- Clinicians should maintain a high index of suspicion for GI manifestations in pediatric COVID-19 cases.
Objectives:
To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms.
Methods:
In this systematic review and meta-analysis, we searched PubMed, Embase, CINAHL and the WHO's database of publications on novel coronavirus. We included English language studies that had described original demographic and clinical characteristics of children diagnosed with COVID-19 and reported on the presence or absence of gastrointestinal symptoms. Meta-analysis was conducted using the random-effects model. The pooled prevalence of gastrointestinal symptoms was expressed as proportion and 95% CI.
Results:
The search identified 269 citations. Thirteen studies (nine case series and four case reports) comprising data for 284 patients were included. Overall, we rated four studies as having a low risk of bias, eight studies as moderate and one study as high risk of bias. In a meta-analysis of nine studies, comprising 280 patients, the pooled prevalence of all gastrointestinal symptoms was 22.8% (95% CI 13.1% to 35.2%; I2=54%). Diarrhoea was the most commonly reported gastrointestinal symptom followed by vomiting and abdominal pain.
Conclusions:
Nearly a quarter of children with COVID-19 have gastrointestinal symptoms. It is important for clinicians to be aware of the gastrointestinal manifestation of COVID-19.
Prospero Registration Number:
CRD42020177569.
Related Concept Videos
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:26Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
01:20Gastrointestinal Motility Disorders
01:17Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.